Planning set to make final decision on Monday Plans for a medicinal cannabis production facility on the Isle of Man have been recommended for approval. Grow Lab Organics has applied to build its production site and headquarters near Ronaldsway. The company’s previously said the development could be built within twelve months of the application being approved. […]

Despite the failure of Amendment 3 in Florida, the company said it will continue expanding in the state. The post Planet 13 cuts losses, grows balance sheet, largely thanks to Florida entrance appeared first on Green Market Report.

Department of Justice JC-445698  – Cannabis Control Section – Deputy Attorney General III DEPUTY ATTORNEY GENERAL III $10,536.00 – $14,879.00 per Month Final Filing Date: 11/12/2024 https://calcareers.ca.gov/CalHrPublic/Jobs/JobPosting.aspx?JobControlId=445698 Job Description and Duties Cannabis Control Section (CCS) deputies represent the state cannabis licensing agency before the Office of Administrative Hearings, represent state cannabis licensing and enforcement agencies in civil […]

COMPLIANCE INVESTIGATOR II – Natural Medicine Division     Apply Salary $70,140.00 – $91,188.00 Annually Location Lakewood, CO Job Type Full Time Job Number TAA-04050-10.2024 Department Department of Revenue Division Natural Medicine Division Opening Date 11/08/2024 Closing Date 11/19/2024 5:00 PM Mountain FLSA Determined by Position Type of Announcement This position is open only to Colorado […]

A partner at Porter Wright, where he serves as co-chair of the firm’s Administrative and Regulatory Law Practice Group, Pennington and a legal team have worked pro-bono for four years so terminally ill patients can get treatments the U.S. Drug Enforcement Administration has criminalized. Pennington represents Dr. Sunil Aggarwal, a Seattle palliative care physician treating […]

Kathryn J. Russo & Catherine A. Cano Details November 7, 2024 Earlier this year, the DEA responded to President Biden’s directive to reschedule cannabis from Schedule I to Schedule III of the Controlled Substances Act. This pivotal change, if finalized, would reclassify marijuana as a drug with moderate to low potential for dependence, strictly for medical use. […]